Literature DB >> 9325111

Assembly of physalis mottle virus capsid protein in Escherichia coli and the role of amino and carboxy termini in the formation of the icosahedral particles.

M Sastri1, R Kekuda, K Gopinath, C T Kumar, J R Jagath, H S Savithri.   

Abstract

The coat protein gene of physalis mottle tymovirus (PhMV) was over expressed in Escherichia coli using pET-3d vector. The recombinant protein was found to self assemble into capsids in vivo. The purified recombinant capsids had an apparent s value of 56.5 S and a diameter of 29(+/-2) nm. In order to establish the role of amino and carboxy-terminal regions in capsid assembly, two amino-terminal deletions clones lacking the first 11 and 26 amino acid residues and two carboxy-terminal deletions lacking the last five and ten amino acid residues were constructed and overexpressed. The proteins lacking N-terminal 11 (PhCPN1) and 26 (PhCPN2) amino acid residues self assembled into T=3 capsids in vivo, as evident from electron microscopy, ultracentrifugation and agarose gel electrophoresis. The recombinant, PhCPN1 and PhCPN2 capsids were as stable as the empty capsids formed in vivo and encapsidated a small amount of mRNA. The monoclonal antibody PA3B2, which recognizes the epitope within region 22 to 36, failed to react with PhCPN2 capsids while it recognized the recombinant and PhCPN1 capsids. Disassembly of the capsids upon treatment with urea showed that PhCPN2 capsids were most stable. These results demonstrate that the N-terminal 26 amino acid residues are not essential for T=3 capsid assembly in PhMV. In contrast, both the proteins lacking the C-terminal five and ten amino acid residues were present only in the insoluble fraction and could not assemble into capsids, suggesting that these residues are crucial for folding and assembly of the particles. Copyright 1997 Academic Press Limited.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9325111     DOI: 10.1006/jmbi.1997.1258

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  7 in total

1.  Physalis Mottle Virus-Like Particles as Nanocarriers for Imaging Reagents and Drugs.

Authors:  Hema Masarapu; Bindi K Patel; Paul L Chariou; He Hu; Neetu M Gulati; Bradley L Carpenter; Reza A Ghiladi; Sourabh Shukla; Nicole F Steinmetz
Journal:  Biomacromolecules       Date:  2017-11-16       Impact factor: 6.988

2.  Physalis Mottle Virus-like Nanoparticles for Targeted Cancer Imaging.

Authors:  He Hu; Hema Masarapu; Yuning Gu; Yifan Zhang; Xin Yu; Nicole F Steinmetz
Journal:  ACS Appl Mater Interfaces       Date:  2019-05-10       Impact factor: 9.229

3.  Vaccination with E. coli recombinant empty viral particles of infectious bursal disease virus (IBDV) confer protection.

Authors:  Arie Rogel; Luna Benvenisti; Ilan Sela; Orit Edelbaum; Edna Tanne; Yehoshua Shachar; Yehuda Zanberg; Tanya Gontmakher; Eli Khayat; Yehuda Stram
Journal:  Virus Genes       Date:  2003-10       Impact factor: 2.332

4.  The cauliflower mosaic virus capsid protein: assembly and nucleic acid binding in vitro.

Authors:  Y Chapdelaine; T Hohn
Journal:  Virus Genes       Date:  1998       Impact factor: 2.332

Review 5.  Virus-like particles: models for assembly studies and foreign epitope carriers.

Authors:  Andrzej Palucha; Adrianna Loniewska; Subbian Satheshkumar; Anna M Boguszewska-Chachulska; Mahadevaiah Umashankar; Malgorzata Milner; Anne-Lise Haenni; Handanahal Subbarao Savithri
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2005

6.  The unique potency of Cowpea mosaic virus (CPMV) in situ cancer vaccine.

Authors:  Sourabh Shukla; Chao Wang; Veronique Beiss; Hui Cai; Torus Washington; Abner A Murray; Xingjian Gong; Zhongchao Zhao; Hema Masarapu; Adam Zlotnick; Steven Fiering; Nicole F Steinmetz
Journal:  Biomater Sci       Date:  2020-09-30       Impact factor: 7.590

Review 7.  Construction and characterization of virus-like particles: a review.

Authors:  Andris Zeltins
Journal:  Mol Biotechnol       Date:  2013-01       Impact factor: 2.695

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.